Search results
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
Live Science via Yahoo News· 5 days agoNew research provides insight into ultra-rare case of secondary cancer in a patient who received CAR...
11-year-old cancer survivor thriving after treatment supported by Alex's Lemonade Stand
CBS News· 2 hours agoThe family of a child fighting pediatric cancer was out of options when a doctor proposed a...
EU regulator mandates label updates on CAR-T cancer therapies
Reuters via AOL· 4 days agoThe European Medicines Agency's (EMA) mandate, which echoes the one issued by the U.S. health...
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
LiveScience· 5 days agoIn an extremely rare case, a patient who received a cell-based cancer treatment later developed a...
Hitting a Home Run for Small-Cell Lung Cancer Patients
Denton Record-Chronicle· 7 days agoThis exciting new treatment uses the patient's immune system to fight cancer. The treatment, called T-cell engager technology, uses the immune system's ...
Postdoc to investigate molecular mechanisms in the field immune-rejuvenation for drug discovery -...
Nature· 1 day agoIn the compelling and unstoppable research in favor of cellular rejuvenation, Sentcell LTD is looking for PhD or Postdoc Researchers to investigate molecular mechanisms and innovative therapies ...
CAR-T Treatment Continues to Astonish in Rheumatologic Diseases
MedPage Today· 7 days agoNew data reported here reinforce the idea that chimeric antigen receptor T-cell (CAR-T) therapy can...
Case study reveals important new details about rare second cancers related to CAR-T therapy
Medical Xpress· 6 days agoA new detailed analysis of a patient's second cancer after receiving CAR-T therapy for the initial cancer provides rare but important insights intended to offer helpful guidance ...
Why Is Penny Stock Mustang Bio Trading Over 190% On Monday? - Mustang Bio (NASDAQ:MBIO)
Benzinga· 1 day agoMonday, the cell therapy-focused company announced that updated data from the ongoing Phase 1/2...
First-in-Disease Use of Kyverna Therapeutics' KYV-101 in Patient With Severe Stiff-Person Syndrome...
Lodi News-Sentinel· 1 day ago"It is extremely encouraging to see this patient improving...